Form 4: Clover Health CEO Sells Shares for Tax Obligations

Clover Health's CEO of Home Care, Brady Priest, disposed of shares to cover tax obligations related to RSU vesting.

Summary

• Brady Patrick Priest, CEO of Home Care at Clover Health Investments, Corp. (CLOV), reported two transactions involving the disposition of Class A Common Stock.
• On January 15, 2026, 18,076 shares were disposed of at a price of $2.81 per share to cover tax obligations upon the vesting of Restricted Stock Units (RSUs) granted on October 15, 2024.
• Following this transaction, Priest beneficially owned 2,210,507 shares of Class A Common Stock.
• On January 18, 2026, an additional 36,923 shares were disposed of at a price of $2.54 per share, also to cover tax obligations upon the vesting of time-based RSUs granted on July 18, 2022.
• After the second transaction, Priest's beneficial ownership stood at 2,173,584 shares of Class A Common Stock.
• Both dispositions were automatic withholdings for tax purposes due to the vesting of 6.25% installments of the original RSU grants.

Sentiment

Score: 5

Explanation: The filing reports routine executive share dispositions for tax obligations upon RSU vesting, which is a standard compensation practice and does not reflect a change in company fundamentals or outlook.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates the executive's continued service to the company, aligning their interests with long-term performance.

Negatives

• The disposition of shares, even for tax purposes, slightly reduces the direct beneficial ownership of the reporting person.

Risks

• No specific risks to the company's operations or financial health were mentioned in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports a routine insider transaction related to executive compensation and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Minimal impact on shareholders as these are routine tax-related transactions associated with executive compensation, not indicative of a change in company performance or strategy.

Next Steps

• Remaining Restricted Stock Units (RSUs) from the October 15, 2024 grant will vest quarterly in equal installments of 6.25%, with the final vesting date on October 15, 2028, subject to continued service.
• Remaining Restricted Stock Units (RSUs) from the July 18, 2022 grant will vest quarterly in equal installments of 6.25%, with the final vesting date on July 18, 2026, subject to continued service.

Key Dates

Recommendation

The Form 4 filing details routine share dispositions by an executive to cover tax obligations upon RSU vesting. This is a standard compensation event and does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation.

Keywords

Clover Health, CLOV, Form 4, Insider Transaction, RSU Vesting, Executive Compensation, Brady Priest, Stock Disposition, Tax Withholding